• search

Aurigene is a contract research, development and manufacturing organization (CRDMO) offering truly integrated services in the discovery, development and commercialization of small and large molecules to global innovative pharma and biotech companies.       

Beyond science, our operations are rooted in the fundamental principles of compliance, information security, quality, and sustainability. As an environmentally responsible company, we continue delivering on our ESG goals. We became water-positive in 2023 and are working on ambitious goals to reduce our carbon footprint. In numbers, we aim to switch to 100% renewable power by 2030 and achieve carbon neutrality in our direct operations (Scope 1 and Scope 2 emissions) by 2030 and a 12.5% reduction in indirect carbon emissions across our supply chain (Scope 3 emissions) by 2030.

 

Our Integrated Services for Small and Large Molecules

In the discovery space, Aurigene boasts a legacy of more than 25 years of operations and has long-term partnerships with two of the top five pharmaceutical companies. We offer chemistry, biology, and integrated services across the life cycle of drug discovery, from target identification to IND filing. We operate in a flexible manner and offer our services in FTE and/or FFS mode; integrated and/or standalone mode.

Leading CRO/CDMO and a long-term partner

We are uniquely positioned to serve our customers and accelerate their journey to the clinic from discovery to commercialization by nurturing long-term partnerships.

Read more about our infrastructure to see how we are positioned to provide end-to-end services:

Read More

 

Why Aurigene Pharmaceutical Services?

20+

years’ experience

900+

scientists

125+

global clients

600+

projects

18

NCEs       
commercialized

16

USFDA inspected       
cGMP facilities

6

Biologics       
commercialized

3

manufacturing countries       
UK, Mexico, India

 

Virtual Tour

 
quots

Client Speak

PROTACs: Research for a life without cancer

PROTACs: Research for a life without cancer

PROTACs:Proteolysis-targeting chimeras (PROTACs) are a rapidly evolving field with promising applications in cancer, neurodegenerative diseases, and other conditions where the regulation of protein levels is crucial.PROTACs are a novel class of small molecules designed to target specific proteins for degradation by the ubiquitin-proteasome system. This approach l...

Read More
CDMO white paper

Advancement in personalized medicine and how the CRDMO industry is part of the solution

Personalized medicine is transforming the healthcare landscape by customizing treatment plans to individual patients’ unique genetic, clinical and environmental characteristics. These are effective and less invasive treatments for a wide range of conditions. Contract Research, Development and Manufacturing Organizations (CRDMOs) play an important role in enabli...

Read More
Quantification (PK evaluation) of small anti-sense oligonucleotides (ASOs) in animal tissues and studying the effect of ASO modifications on tissue accumulation and activity

Quantification (PK evaluation) of small anti-sense oligonucleotides (ASOs) in animal tissues and studying the effect of ASO modifications on tissue accumulation and activity

Objective: To standardize quantification methods for small ASOs in various animal tissues Study design: Tissues received from the ASO dosed animals were lysed for evaluation Hybridization based qPCR and ELISA methods were evaluated for ASO quantification Gene expression analysis using RT-qPCR to assess ASO activityChallenge: Several methods are available to quant...

Read More

A simple RP-HPLC method development and verification of the Dissolution of Bromelain-A Complex mixture of proteolytic enzymes, in delayed release tablets

2024

Bromelain is a complex natural mixture of proteolytic enzymes derived from pineapple (Ananas cosmosus), which has good therapeutic properties. Bromelain can be found in all tissues of pineapple plants, including the stem, fruit, and leaves. Bromelain plays an important role in the treatment of many diseases such as soft tissue inflammation and edema, deep derma, ...

Read More
View All

Events

Events

Know More

Webinars

Know More

×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack